Chinook, Aduro Merger Plan Sets Up New Kidney Disease-Focused Biotech

Chinook Therapeutics and Aduro Biotech, each pursuing different approaches to the same rare disease, are now converging on a path to combine their operations into a single company focused on developing new treatments for kidney disorders.